CRP and spondyloarthropathy: Unexpected IFN-I downregulation, albeit is reminiscent to findings in experimental models of spondyloarthritis, was observed regardless of CRP and treatment modalities and may be indicative of dysregulated innate immune regulation in PsA pathogenesis.